AF
MED icon

Amalgamated Financial’s Medifast MED Stock Holding History

Amalgamated Financial’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$971K Buy
+5,688
New +$1.07M 0.01% 1186

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Amalgamated Financial's MED Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Medifast (MED) in Q1 2022: 5,688 shares worth $971K. The stake represents 0.01% of the portfolio and ranks #1186 among its holdings.

288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Amalgamated Financial held 5,688 shares of Medifast worth $971K as of Q1 2022.
  • Medifast was a new Amalgamated Financial position in Q1 2022.
  • Medifast made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1186 holding.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.